Gossuin, Sandre, et al. describe the design of magnetic nanoparticles with optimised relaxivity for magnetic resonance imaging (MRI).
Gossuin, Sandre, et al. describe the design of magnetic nanoparticles with optimised relaxivity for magnetic resonance imaging (MRI).
Visiopharm and Hamamatsu have reached a reseller agreement for Visiopharm’s Quantitative Digital Pathology (QDP) solutions.